| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
CD14+/CD31+ monocytes expanded by UM171 correct hemophilia A in zebrafish upon lentiviral gene transfer of factor VIII
|
Elnaggar, Muhammad
|
|
|
7 |
5 |
p. 697-711
|
artikel
|
| 2 |
Cost-effectiveness of chimeric antigen receptor T-cell therapy in adults with relapsed or refractory follicular lymphoma
|
Potnis, Kunal C.
|
|
|
7 |
5 |
p. 801-810
|
artikel
|
| 3 |
Cuker A, Tseng EK, Nieuwlaat R, et al. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients. Blood Adv. 2021;5(20):3951-3959.
|
|
|
|
7 |
5 |
p. 811
|
artikel
|
| 4 |
Downregulated KLF2 in polycythemia vera and essential thrombocythemia induces prothrombotic gene expression
|
Song, Jihyun
|
|
|
7 |
5 |
p. 712-717
|
artikel
|
| 5 |
Early initiation of low-dose gilteritinib maintenance improves posttransplant outcomes in patients with R/R FLT3mut AML
|
Terao, Toshiki
|
|
|
7 |
5 |
p. 681-686
|
artikel
|
| 6 |
Editorial Board
|
|
|
|
7 |
5 |
p. i
|
artikel
|
| 7 |
Efficacy, safety, and molecular response predictors of oral ixazomib and short-course rituximab in untreated iNHL
|
Graf, Solomon A.
|
|
|
7 |
5 |
p. 687-696
|
artikel
|
| 8 |
Front Matter
|
|
|
|
7 |
5 |
p. ii
|
artikel
|
| 9 |
HLA-DR expression on monocytes and outcome of anti-CD19 CAR T-cell therapy for large B-cell lymphoma
|
Bourbon, Estelle
|
|
|
7 |
5 |
p. 744-755
|
artikel
|
| 10 |
Late effects in patients with mantle cell lymphoma treated with or without autologous stem cell transplantation
|
Ekberg, Sara
|
|
|
7 |
5 |
p. 866-874
|
artikel
|
| 11 |
Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type diffuse large B-cell lymphoma
|
Bewicke-Copley, Findlay
|
|
|
7 |
5 |
p. 845-855
|
artikel
|
| 12 |
Lévy R, Fusaro M, Guerin F, et al. Efficacy of ruxolitinib in subcutaneous panniculitis-like T-cell lymphoma and hemophagocytic lymphohistiocytosis. Blood Adv. 2020;4(7):1383-1387.
|
|
|
|
7 |
5 |
p. 800
|
artikel
|
| 13 |
Oñate G, Bataller A, Garrido A, et al; CETLAM (Spanish Cooperative Group for the Diagnosis and Treatment of Acute Myeloid Leukemia and Myelodysplastic Syndromes). Prognostic impact of DNMT3A mutation in acute myeloid leukemia with mutated NPM1. Blood Adv. 2022;6(3):882-890.
|
|
|
|
7 |
5 |
p. 875
|
artikel
|
| 14 |
Patient-specific comorbidities as prognostic variables for survival in myelofibrosis
|
Sochacki, Andrew L.
|
|
|
7 |
5 |
p. 756-767
|
artikel
|
| 15 |
Phase 1 study of CART-ddBCMA for the treatment of subjects with relapsed and refractory multiple myeloma
|
Frigault, Matthew J.
|
|
|
7 |
5 |
p. 768-777
|
artikel
|
| 16 |
sCD25 as an independent adverse prognostic factor in adult patients with HLH: results of a multicenter retrospective study
|
Wimmer, Thomas
|
|
|
7 |
5 |
p. 832-844
|
artikel
|
| 17 |
Second malignancies among older patients with classical myeloproliferative neoplasms treated with hydroxyurea
|
Wang, Rong
|
|
|
7 |
5 |
p. 734-743
|
artikel
|
| 18 |
Spatiotemporal assessment of immunogenomic heterogeneity in multiple myeloma
|
Merz, Maximilian
|
|
|
7 |
5 |
p. 718-733
|
artikel
|
| 19 |
The promising efficacy of a risk-based letermovir use strategy in CMV-positive allogeneic hematopoietic cell recipients
|
Sourisseau, Mathilde
|
|
|
7 |
5 |
p. 856-865
|
artikel
|
| 20 |
Tracking the progeny of adoptively transferred virus-specific T cells in patients posttransplant using TCR sequencing
|
Huisman, W.
|
|
|
7 |
5 |
p. 812-827
|
artikel
|
| 21 |
Transcriptional reprogramming of infiltrating neutrophils drives lung pathology in severe COVID-19 despite low viral load
|
Eddins, Devon J.
|
|
|
7 |
5 |
p. 778-799
|
artikel
|
| 22 |
Validation of the ALFA-1200 model in older patients with AML treated with intensive chemotherapy
|
Abbas, Hussein A.
|
|
|
7 |
5 |
p. 828-831
|
artikel
|
Tijdschrift beschrijving